VAN PLEW DANIEL P 1411984 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-25 | 2023-08-23 | 2023-08-23 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | acq | 23125.0 | 51.81 | 2.17 | 381.4 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 44633.0 | 106.74 (REGN) |
| 2023-08-25 | 2023-08-23 | 2023-08-23 to 2023-08-24 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | dsp | 23125.0 | 51.81 | 2.17 | 842.41 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F S | 21508.0
|
106.74 (REGN) |
| 2023-08-25 | 2023-08-23 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | holding | 1080.0 | 0 | 0.1 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 106.74 (REGN) | ||
| 2023-08-25 | 2023-08-23 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | holding | 12376.0 | 0 | 1.16 | 0.0 | 2023 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 106.74 (REGN) | ||
| 2023-12-12 | 2023-12-08 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | holding | 12376.0 | 0 | 1.16 | 0.0 | 2023 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-12 | 2023-12-08 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | holding | 1080.0 | 0 | 0.1 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-12 | 2023-12-08 | 2023-12-08 to 2023-12-11 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | dsp | 4329.0 | 17.52 | 0.4 | 844.01 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 20378.0
|
107.13 (REGN) |
| 2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | acq | 3199.0 | 13.56 | 0.3 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code A | 23599.0 | 107.13 (REGN) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | dsp | 24941.0 | 44.73 | 2.31 | 951.68 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 30812.0
|
107.94 (REGN) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | acq | 35375.0 | 75.02 | 3.28 | 378.3 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 47153.0
|
107.94 (REGN) |
| 2024-02-13 | 2024-02-09 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | holding | 12376.0 | 0 | 1.15 | 0.0 | 2023 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-13 | 2024-02-09 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | holding | 1084.0 | 0 | 0.1 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-16 | 2024-02-14 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | holding | 12376.0 | 0 | 1.15 | 0.0 | 2023 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-16 | 2024-02-14 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | holding | 1084.0 | 0 | 0.1 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-16 | 2024-02-14 | 2024-02-14 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | dsp | 10434.0 | 33.86 | 0.97 | 942.28 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 20378.0
|
107.94 (REGN) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-25 | 2023-08-23 | 2023-08-23 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | dsp | 23125.0 | 50.0 | 2.17 | 381.4 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 23125.0 | 106.74 (REGN) |
| 2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | acq | 11473.0 | 100.0 | 1.07 | 843.79 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code A | 11473.0 | 107.13 (REGN) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Van Plew Daniel P | EVP & GENERAL MGR, INDUSTRIAL | dsp | 35375.0 | 100.0 | 3.28 | 378.3 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 0.0
|
107.94 (REGN) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)